Hemostasis Management

This channel includes news and new technology innovations for devices to help stop bleeding at vascular access sites. These include coated or treated bandages to accelorate or augment the clotting cascade, vascular closure devices and compression devices, including radial artery compression systems.

Technology | Vascular Closure Devices | November 05, 2018

November 2, 2018 — Cordis, a Cardinal Health company, today announced the U.S. launch of Mynx Control...

The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first antidote indicated for patients treated with rivaroxaban (Xarelto) and apixaban (Eliquis), when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.

The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first antidote indicated for patients treated with rivaroxaban (Xarelto) and apixaban (Eliquis), when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.

 

Feature | Antiplatelet and Anticoagulation Therapies | May 07, 2018

May 7, 2018 — The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first...

Vascade Vascular Closure System Approved for Femoral Vein Closure
Technology | Vascular Closure Devices | April 10, 2018

April 10, 2018 – Cardiva Medical announced the company received U.S. Food and Drug Administration (FDA) approval for...

The bioresorbable Cordis Mynx Grip vascular closure device seals arteriotomies without use of permanent hardware.

The bioresorbable Cordis MynxGrip vascular closure device seals arteriotomies without use of permanent hardware.

Feature | Vascular Closure Devices | January 22, 2018 | Dave Fornell

While manual compression remains the gold standard for hemostasis of catheterization vascular access site...

angioseal, angio-seal, terumo, St. Jude, vascular closure devices
News | Vascular Closure Devices | October 18, 2016

October 18, 2016 — Abbott and St. Jude Medical Inc. announced today an agreement to sell certain products from their...

Vivasure Medical, Closure Device, Series C financing
News | Vascular Closure Devices | September 12, 2016

September 12, 2016 — Vivasure Medical announced last week that the company has completed a Series C financing of €16...

nanoparticles, blood clotting, internal bleeding, American Chemical Society study, Erin B. Lavik

Nanoparticles (green) help form clots in an injured liver. The researchers added color to the scanning electron microscopy image after it was taken. Image courtesy of Erin Lavik, Ph.D.

News | Hemostasis Management | August 24, 2016

August 24, 2016 — Whether severe trauma occurs on the battlefield or the highway, saving lives often comes down to...

Rex medical, Closer Vascular Sealing System, VSS, vascular closure, bioresorbable vascular closure device

A close up view of the Rex Medical Closer Vascular Sealing System components.

Technology | Vascular Closure Devices | August 03, 2016

August 3, 2016 — The U.S. Food and Drug Administration (FDA) has granted market clearance to Rex Medical’s...

Vivasure Medical, PerQSeal, vascular closure device, CE Mark
News | Vascular Closure Devices | January 18, 2016

January 18, 2016 — Vivasure Medical announced Conformité Européenne (CE) Mark approval of the world’s first fully...

News | Hemostasis Management | January 06, 2016

January 6, 2016 — The Medicines Company announced Dec. 18 it has entered into a purchase agreement pursuant to which...

News | Vascular Closure Devices | December 16, 2015

December 16, 2015 — Scientists at CBSET have presented preclinical evidence that the Manta Large Bore...

platelet-like particles, PLPs, clotting, substitute, Carver, Lyon, NIBIB

Cartoon representation of a deformable platelet-like particle with fibrin nanobodies attached

Feature | Antiplatelet and Anticoagulation Therapies | July 13, 2015

July 13, 2015 - Researchers have created tiny gel particles that can perform the same essential functions as...

News | March 30, 2015

March 30, 2015 — The Medicines Company announced that the European Commission has granted marketing authorization...

Overlay Init